Enhancing Community Health Through Patient Navigation, Advocacy and Social Support

Key facts

Sponsor

University of Calgary

Principal Investigator

Kerry A McBrien, MD, MPH, RDCS

University of Calgary

Intervention

ENCOMPASS Intervention(behavioral)

Enrollment

176 target

Eligibility

18 years · All sexes

Timeline

2018 – 2024

Study locations (1)

• Mosaic Primary Care Network, Calgary, Alberta, Canada

Collaborators

Alberta Innovates Health Solutions · Canadian Diabetes Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Idiopathic pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNANCT06829589
  Retrieval of Economic Incentives and Information on Quality-of-care Indicators in Primary Care
  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
• RECRUITINGNANCT06605794
  FreeFlow Percutaneous Atrial Septal Shunt for IPAH
  Shanghai Zhongshan Hospital
• ACTIVE NOT RECRUITINGNCT05723185
  Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational Study
  Rovere Querini Patrizia
• RECRUITINGNANCT05584722
  Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
  Vanderbilt University Medical Center
• ACTIVE NOT RECRUITINGPHASE2NCT05679570
  Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
  International University of Health and Welfare
• RECRUITINGNCT04756076
  Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
  Jiapeng Huang

See all trials for Idiopathic pulmonary arterial hypertension →